2016-09865. New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship; Correction

Start Preamble
AGENCY:

Food and Drug Administration, HHS.

ACTION:

Final rule; technical amendment; correcting amendments.

SUMMARY:

The Food and Drug Administration (FDA) published a document in the Federal Register of April 18, 2016 (81 FR 22520), amending the animal drug regulations to reflect application-related actions for new animal drug applications (NADAs) and abbreviated new animal drug applications (ANADAs) during January and February 2016. That rule included two amendatory instructions that cited incorrect sections of 21 CFR part 524.

DATES:

Effective: April 28, 2016.
Start Further Info
FOR FURTHER INFORMATION CONTACT:

George K. Haibel, Center for Veterinary Medicine (HFV-6), Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 240-402-5689, george.haibel@fda.hhs.gov.
End Further Info End Preamble Start Supplemental Information
SUPPLEMENTARY INFORMATION:

In FR Doc. 2016-08827, appearing on page 22520 in the Federal Register of Monday, April 18, 2016, the following corrections are made:

On page 22524, in the third column, remove amendatory instructions 35 and 36.
Start List of Subjects
List of Subjects in 21 CFR Part 524
- Animal drugs
End List of Subjects
Accordingly, 21 CFR part 524 is corrected by making the following correcting amendments:
Start Part
PART 524—OPHTHALMIC AND TOPICAL DOSAGE FORM NEW ANIMAL DRUGS
End Part Start Amendment Part
1. The authority citation for part 524 continues to read as follows:
End Amendment Part Start Authority
Authority: 21 U.S.C. 360b.
End Authority

§ 524.1193

[Amended]

Start Amendment Part
2. In paragraph (b)(2) of § 524.1193, remove “000859” and in its place add “016592”.
End Amendment Part

§ 524.1484k

[Amended]

Start Amendment Part
3. In § 524.1484k, revise the section heading to read: Neomycin and prednisolone suspension.
End Amendment Part Start Signature

Dated: April 22, 2016.

Tracey Forfa,

Acting Director, Center for Veterinary Medicine.

End Signature End Supplemental Information

[FR Doc. 2016-09865 Filed 4-27-16; 8:45 am]

BILLING CODE 4164-01-P